Literature DB >> 22067756

Assessment of significant factors affecting acceptability of home administration of misoprostol for medical abortion.

Helena Kopp Kallner1, Christian Fiala, Kristina Gemzell-Danielsson.   

Abstract

BACKGROUND: Knowledge on factors affecting acceptability of medical abortion with mifepristone followed by home administration of misoprostol is scarce. The objective of this study was therefore to assess factors affecting acceptability and experience of home use of misoprostol for medical abortion up to 63 days' gestation. STUDY
DESIGN: Prospective observational study with acceptability assessed through questionnaires. Factors affecting acceptability were analyzed using multivariate logistic regression.
RESULTS: A total of 395 women were included. Independent factors for acceptability were having a partner/friend present and having a positive low-sensitivity urine hCG at follow-up, although most of these patients had successful abortions. Age, gestational length and requirement of extra pain medication did not affect acceptability.
CONCLUSION: Home administration of misoprostol is highly acceptable. Increasing the number of complete abortions should be a focus of future research. Women should be encouraged to have a partner/friend present during home administration of misoprostol. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22067756     DOI: 10.1016/j.contraception.2011.08.009

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  10 in total

1.  Barriers to accessing abortion services and perspectives on using mifepristone and misoprostol at home in Great Britain.

Authors:  Abigail R A Aiken; Katherine A Guthrie; Marlies Schellekens; James Trussell; Rebecca Gomperts
Journal:  Contraception       Date:  2017-09-20       Impact factor: 3.375

Review 2.  Pain management for medical abortion before 14 weeks' gestation.

Authors:  John J Reynolds-Wright; Mulat A Woldetsadik; Chelsea Morroni; Sharon Cameron
Journal:  Cochrane Database Syst Rev       Date:  2022-05-13

3.  Clinical Outcomes and Women's Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa.

Authors:  Deborah Constant; Jane Harries; Thokozile Malaba; Landon Myer; Malika Patel; Gregory Petro; Daniel Grossman
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

4.  Women's Acceptability of Misoprostol Treatment for Incomplete Abortion by Midwives and Physicians - Secondary Outcome Analysis from a Randomized Controlled Equivalence Trial at District Level in Uganda.

Authors:  Amanda Cleeve; Josaphat Byamugisha; Kristina Gemzell-Danielsson; Nazarius Mbona Tumwesigye; Susan Atuhairwe; Elisabeth Faxelid; Marie Klingberg-Allvin
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

5.  Self-management of first trimester medical termination of pregnancy: a qualitative study of women's experiences.

Authors:  C Purcell; S Cameron; J Lawton; A Glasier; J Harden
Journal:  BJOG       Date:  2017-06-14       Impact factor: 6.531

6.  "Who Wants to Go Repeatedly to the Hospital?" Perceptions and Experiences of Simplified Medical Abortion in Rajasthan, India.

Authors:  Kirti Iyengar; Marie Klingberg Allvin; Sharad D Iyengar; Kristina Gemzell Danielsson; Birgitta Essén
Journal:  Glob Qual Nurs Res       Date:  2016-12-19

7.  Effectiveness and safety of sublingual misoprostol in medical treatment of the 1st trimester miscarriage: experience of off-label use in Korea.

Authors:  Jung Yeon Park; Hyo Jeong Ahn; Ba Raem Yoo; Kyu Ri Hwang; Taek Sang Lee; Hye Won Jeon; Sun Min Kim; Byoung Jae Kim
Journal:  Obstet Gynecol Sci       Date:  2018-03-02

8.  Acceptability of Home-Assessment Post Medical Abortion and Medical Abortion in a Low-Resource Setting in Rajasthan, India. Secondary Outcome Analysis of a Non-Inferiority Randomized Controlled Trial.

Authors:  Mandira Paul; Kirti Iyengar; Birgitta Essén; Kristina Gemzell-Danielsson; Sharad D Iyengar; Johan Bring; Sunita Soni; Marie Klingberg-Allvin
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

9.  Sociodemographic Characteristics of Women Able to Obtain Medication Abortion Before and After Ohio's Law Requiring Use of the Food and Drug Administration Protocol.

Authors:  Ushma D Upadhyay; Nicole E Johns; Alice F Cartwright; Tanya E Franklin
Journal:  Health Equity       Date:  2018-07-01

10.  How task-sharing in abortion care became the norm in Sweden: A case study of historic and current determinants and events.

Authors:  Margit Endler; Amanda Cleeve; Ingrid Sääv; Kristina Gemzell-Danielsson
Journal:  Int J Gynaecol Obstet       Date:  2020-07       Impact factor: 3.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.